Coverage
-
November 27, 2023
Teva Pharmaceuticals International GmbH has moved in Massachusetts federal court to permanently drop an infringement case against Eli Lilly and Co. over a migraine drug — an action taken after the Patent Trial and Appeal Board found two patents related to the drug and its use invalid.
3 other articles on this case.
View all »